BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21334569)

  • 1. Impact of physical and sexual abuse on treatment response in the Treatment of Resistant Depression in Adolescent Study (TORDIA).
    Shamseddeen W; Asarnow JR; Clarke G; Vitiello B; Wagner KD; Birmaher B; Keller MB; Emslie G; Iyengar S; Ryan ND; McCracken JT; Porta G; Mayes T; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2011 Mar; 50(3):293-301. PubMed ID: 21334569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
    Brent D; Emslie G; Clarke G; Wagner KD; Asarnow JR; Keller M; Vitiello B; Ritz L; Iyengar S; Abebe K; Birmaher B; Ryan N; Kennard B; Hughes C; DeBar L; McCracken J; Strober M; Suddath R; Spirito A; Leonard H; Melhem N; Porta G; Onorato M; Zelazny J
    JAMA; 2008 Feb; 299(8):901-913. PubMed ID: 18314433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study.
    Asarnow JR; Porta G; Spirito A; Emslie G; Clarke G; Wagner KD; Vitiello B; Keller M; Birmaher B; McCracken J; Mayes T; Berk M; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):772-81. PubMed ID: 21784297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
    Asarnow JR; Emslie G; Clarke G; Wagner KD; Spirito A; Vitiello B; Iyengar S; Shamseddeen W; Ritz L; Birmaher B; Ryan N; Kennard B; Mayes T; DeBar L; McCracken J; Strober M; Suddath R; Leonard H; Porta G; Keller M; Brent D
    J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):330-339. PubMed ID: 19182688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.
    Lynch FL; Dickerson JF; Clarke G; Vitiello B; Porta G; Wagner KD; Emslie G; Asarnow JR; Keller MB; Birmaher B; Ryan ND; Kennard B; Mayes T; DeBar L; McCracken JT; Strober M; Suddath RL; Spirito A; Onorato M; Zelazny J; Iyengar S; Brent D
    Arch Gen Psychiatry; 2011 Mar; 68(3):253-62. PubMed ID: 21383263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
    Vitiello B; Emslie G; Clarke G; Wagner KD; Asarnow JR; Keller MB; Birmaher B; Ryan ND; Kennard B; Mayes TL; DeBar L; Lynch F; Dickerson J; Strober M; Suddath R; McCracken JT; Spirito A; Onorato M; Zelazny J; Porta G; Iyengar S; Brent DA
    J Clin Psychiatry; 2011 Mar; 72(3):388-96. PubMed ID: 21208583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
    Brent DA; Emslie GJ; Clarke GN; Asarnow J; Spirito A; Ritz L; Vitiello B; Iyengar S; Birmaher B; Ryan ND; Zelazny J; Onorato M; Kennard B; Mayes TL; Debar LL; McCracken JT; Strober M; Suddath R; Leonard H; Porta G; Keller MB
    Am J Psychiatry; 2009 Apr; 166(4):418-26. PubMed ID: 19223438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance use and the treatment of resistant depression in adolescents.
    Goldstein BI; Shamseddeen W; Spirito A; Emslie G; Clarke G; Wagner KD; Asarnow JR; Vitiello B; Ryan N; Birmaher B; Mayes T; Onorato M; Zelazny J; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1182-92. PubMed ID: 19858762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.
    Shamseddeen W; Clarke G; Keller MB; Wagner KD; Birmaher B; Emslie GJ; Ryan N; Asarnow JR; Porta G; Brent DA
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):29-36. PubMed ID: 22251024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS).
    Lewis CC; Simons AD; Nguyen LJ; Murakami JL; Reid MW; Silva SG; March JS
    J Am Acad Child Adolesc Psychiatry; 2010 Feb; 49(2):132-40. PubMed ID: 20215935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy.
    Wagner KD; Asarnow JR; Vitiello B; Clarke G; Keller M; Emslie GJ; Ryan N; Porta G; Iyengar S; Ritz L; Zelanzny J; Onorato M; Brent D
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):5-10. PubMed ID: 22251022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial.
    Woldu H; Porta G; Goldstein T; Sakolsky D; Perel J; Emslie G; Mayes T; Clarke G; Ryan ND; Birmaher B; Wagner KD; Asarnow JR; Keller MB; Brent D
    J Am Acad Child Adolesc Psychiatry; 2011 May; 50(5):490-8. PubMed ID: 21515198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break.
    Shamseddeen W; Clarke G; Wagner KD; Ryan ND; Birmaher B; Emslie G; Asarnow JR; Porta G; Mayes T; Keller MB; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1140-8. PubMed ID: 22024002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression.
    McMakin DL; Olino TM; Porta G; Dietz LJ; Emslie G; Clarke G; Wagner KD; Asarnow JR; Ryan ND; Birmaher B; Shamseddeen W; Mayes T; Kennard B; Spirito A; Keller M; Lynch FL; Dickerson JF; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2012 Apr; 51(4):404-11. PubMed ID: 22449646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
    Hilton RC; Rengasamy M; Mansoor B; He J; Mayes T; Emslie GJ; Porta G; Clarke GN; Wagner KD; Birmaher B; Keller MB; Ryan N; Shamseddeen W; Asarnow JR; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2013 May; 52(5):482-92. PubMed ID: 23622849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression.
    Rengasamy M; Mansoor BM; Hilton R; Porta G; He J; Emslie GJ; Mayes T; Clarke GN; Wagner KD; Keller MB; Ryan ND; Birmaher B; Shamseddeen W; Asarnow JR; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2013 Apr; 52(4):370-7. PubMed ID: 23582868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.
    Emslie GJ; Mayes T; Porta G; Vitiello B; Clarke G; Wagner KD; Asarnow JR; Spirito A; Birmaher B; Ryan N; Kennard B; DeBar L; McCracken J; Strober M; Onorato M; Zelazny J; Keller M; Iyengar S; Brent D
    Am J Psychiatry; 2010 Jul; 167(7):782-91. PubMed ID: 20478877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings.
    Kennard BD; Clarke GN; Weersing VR; Asarnow JR; Shamseddeen W; Porta G; Berk M; Hughes JL; Spirito A; Emslie GJ; Keller MB; Wagner KD; Brent DA
    J Consult Clin Psychol; 2009 Dec; 77(6):1033-41. PubMed ID: 19968380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cognitive-behavioural therapy and pharmacotherapy for adolescent depression: Does it improve outcomes compared with monotherapy?
    Vitiello B
    CNS Drugs; 2009; 23(4):271-80. PubMed ID: 19374457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.